Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Heart Journal

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2006.02.007PMID 16923409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy

  2011cited by this paper
• Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

  2006cited by this paper
• Clinical applications of stem cells for the heart.

  2005cited by this paper
• Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety

  2005cited by this paper
• Repair of Infarcted Myocardium Mediated by Transplanted Bone Marrow–Derived CD34+ Stem Cells in a Nonhuman Primate Model

  2005cited by this paper
• Bone Marrow Cells Differentiate in Cardiac Cell Lineages After Infarction Independently of Cell Fusion

  2004cited by this paper
• Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction

  2004cited by this paper
• Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

  2004cited by this paper
• Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

  2004cited by this paper
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

  2004cited by this paper
• Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

  2004cited by this paper
• Transplantation of Autologous Fresh Bone Marrow Into Infarcted Myocardium: A Word of Caution

  2003cited by this paper
• Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging

  2003cited by this paper
• Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans

  2002cited by this paper
• Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation.

  2002cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Mobilized bone marrow cells repair the infarcted heart, improving function and survival

  2001cited by this paper
• Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

  2001cited by this paper

• Bone marrow adipocytes fuel emergency hematopoiesis after myocardial infarction

  2023cites this paper
• Bone-Marrow Stem Cells and Acellular Human Amniotic Membrane in a Rat Model of Heart Failure

  2021cites this paper
• Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes.

  2018cites this paper
• Ipotesi di lavoro Sperimentazioni cliniche di terapia cellulare cardiaca in Italia : come procedere ?

  2018cites this paper
• Angiogenic Integrity Preservation/Restoration: Hit for Vascular Endothelial Growth Factor Prone Therapeutic Coronary Revascularization

  2017cites this paper
• Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time.

  2017cites this paper
• The influence of microvascular injury on native T1 and T2* relaxation values after acute myocardial infarction: implications for non-contrast-enhanced infarct assessment

  2017cites this paper
• Adverse outcomes following percutaneous transcatheter interventions

  2017cites this paper
• The relationship between terminal QRS distortion on initial ECG and final infarct size at 4months in conventional ST- segment elevation myocardial infarct patients.

  2016cites this paper
• Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy.

  2016cites this paper
• In vivo assessment of myocardial viability after acute myocardial infarction: A head-to-head comparison of the perfusable tissue index by PET and delayed contrast-enhanced CMR

  2016cites this paper
• New insights in management and prognosis in acute myocardial infarction

  2015cites this paper
• Percutaneous coronary intervention in acute myocardial infarction: from procedural considerations to long term outcomes

  2015cites this paper
• Stem cell treatment for acute myocardial infarction.

  2015cites this paper
• Cardiac magnetic resonance infarct heterogeneity: is it ready to be used on patients for the prevention of sudden cardiac death?

  2014cites this paper
• Cell therapy for cardiac repair—lessons from clinical trials

  2014cites this paper
• Recent advancements in tissue engineering for stem cell-based cardiac therapies.

  2013cites this paper
• Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction.

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) Monocytes in ischemic heart disease

  2013cites this paper
• Choice of cell-delivery route for successful cell transplantation therapy for the heart.

  2013cites this paper
• A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.

  2012cites this paper
• Stem cell treatment for acute myocardial infarction.

  2012cites this paper
• Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe?

  2012influential citation
• From Bench to Bedside: What Physicians Need to Know About Endothelial Progenitor Cells

  2011cites this paper
• Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.

  2011cites this paper
• Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomiz

  2011cites this paper
• Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.

  2011influential citation
• From bench to bedside: what physicians need to know about endothelial progenitor cells.

  2011cites this paper
• Transcriptome Analysis in Endothelial Progenitor Cell Biology

  2011cites this paper
• Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial.

  2011cites this paper
• Cell therapy for heart failure: the need for a new therapeutic strategy

  2010cites this paper
• Is the Myocardial Blush Grade Scored by the Operator During Primary Percutaneous Coronary Intervention of Prognostic Value in Patients With ST-Elevation Myocardial Infarction in Routine Clinical Practice?

  2010cites this paper
• Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography

  2010cites this paper
• Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium

  2010cites this paper
• A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.

  2010cites this paper
• Value and limitations of electromechanical endocardial mapping in the assessment of global and regional left ventricular function and transmural extent of infarction: a comparison with cardiovascular magnetic resonance.

  2010cites this paper
• Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.

  2010cites this paper
• Myocardial Regeneration: Cell-Therapy After Reperfusion in Patients with ST-Elevation Myocardial Infarction

  2010cites this paper
• Innocuité et efficacité de l’angiogénèse thérapeutique comme thérapie innovante des patients ayant une ischémie critique des membres inférieurs

  2010cites this paper
• Clinical and functional outcomes after revascularization strategies in acute coronary syndromes

  2010cites this paper
• Stamm- und progenitorzellbasierte Therapieansätze

  2010cites this paper
• Left ventricular function after STEMI: developments in diagnostics and cell therapy

  2009cites this paper
• Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells

  2009cites this paper
• Cell therapy for myocardial regeneration.

  2009cites this paper
• Endothelial progenitor cell-based neovascularization: implications for therapy.

  2009cites this paper
• Intracoronary delivery of stem cells in patients with acute myocardial infarction. The clinical experience obtained to date and prospects

  2009cites this paper
• Cellular Cardiomyoplasty: What Have We Learned?

  2009cites this paper
• Intrakoronární aplikace kmenových buněk u nemocných s akutním infarktem myokardu , dosavadní klinické zkušenosti a perspektiva

  2009cites this paper
• University of Groningen Left ventricular function after STEMI Vleuten

  2009cites this paper
• Stem cell treatment for acute myocardial infarction.

  2008cites this paper
• Recovery and functional activity of mononuclear bone marrow and peripheral blood cells after different cell isolation protocols used in clinical trials for cell therapy after acute myocardial infarction.

  2008cites this paper
• Advanced clinical approaches in complex cardiovascular disease

  2008cites this paper
• Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results

  2008cites this paper
• CORONARY ARTERY DISEASE Original Studies Intracoronary Infusion of Autologous Mononuclear Bone Marrow Cells in Patients With Acute Myocardial Infarction Treated With Primary PCI: Pilot Study of the Multicenter HEBE Trial

  2008influential citation
• Cell transplantation for cardiac regeneration: where do we stand?

  2008cites this paper
• The difference between ballistocardiography and stem cells

  2008cites this paper
• Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells.

  2007cites this paper
• Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.

  2007cites this paper